Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Becton, Dickinson and Company

BDXA•NYSE
Healthcare
Medical - Instruments & Supplies
$59.24
$-1.36(-2.24%)
U.S. Market opens in NaNh NaNm

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap55.9B
P/E Ratio30.00
EPS (TTM)$2.76
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BDXA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDXA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.00 and a market capitalization of 55.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-1.58%
5-Year Change
2.14%
All-Time (Max) Change
13.49%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateMay 11, 2017
CountryNaN

Frequently Asked Questions